CurrentEndo
Get Weekly

Topic · page 2 of 64

Obesity

Overweight and obesity in adults and children: weight-lowering drugs, lifestyle, metabolic and bariatric surgery against other treatment, weight-related disease, lipodystrophy

Briefs 41–80 of 2,541 placed here, newest publication first

Briefs in Obesity

Newest publication first

  1. Obesity (Silver Spring)

    Trends in GLP ‐1 Receptor Agonist Prescribing Without an Apparent FDA ‐Approved Indication

    Cohort study

  2. Pediatr Obes

    Affective States and Ultra‐Processed Food Intake in Youth With Overweight or Obesity: Evidence From Laboratory and Ecological Momentary Assessment Studies

    Research article

  3. Pediatr Obes

    Impact of Meal Caloric Content on the Thermic Effect of Food in Adolescents With Obesity

    Randomized controlled trial

  4. Int J Obes (Lond)

    ADRB3, LEPR, FTO and PPARG variants contribute to obesity-related metabolic syndrome in Brazilian adults: a polygenic risk score approach

    Case-control study

  5. Diabetes Obes Metab

    Real‐World Adverse Event Reporting Patterns of Tirzepatide Versus Semaglutide: A Stratified Study of General and Healthcare Professional Cohorts in FAERS

    Research article

  6. Diabetes Obes Metab

    Effect of Semaglutide on Thigh Skeletal Muscle Volume, Fat Infiltration and Physical Function in People With Obesity: Secondary Analysis of STEP UP

    Secondary analysis

  7. Diabetes Obes Metab

    Preclinical and First‐In‐Human Evaluation of Ribupatide ( HRS9531 ), a Dual GLP ‐1/ GIP Receptor Agonist

    Research article

  8. Endocr Pract

    Changes in Abdominal Adiposity and Associations with Metabolic Health Markers Following Tirzepatide in Japanese Participants with Obesity Disease: Results from the SURMOUNT-J Study

    Secondary analysis

  9. Endocr Pract

    Changes in Body Composition Assessed by Bioelectrical Impedance Analysis in Patients Treated With Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Experience

    Cohort study

  10. Int J Obes (Lond)

    Effects of nocturnal intermittent hypoxia on metabolic syndrome in Japanese adults without abdominal obesity

    Cohort study

  11. Obesity (Silver Spring)

    Impact of Dietetic Counseling Combined With Digital Tools on Obesity‐Related Indices in Greek Adults: The GATEKEEPER Study

    Randomized controlled trial

  12. Diabetes Obes Metab

    Predicting the Long‐Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN ‐1 Trial

    Secondary analysis

  13. Diabetes Obes Metab

    Effectiveness, Safety and Pharmacokinetics of BGM0504 , a Dual GLP ‐1/ GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double‐Blind, Placebo‐Controlled Trial

    Randomized controlled trial

  14. Diabetes Obes Metab

    Efficacy and Safety of a Novel Reversible Gastric Bypass Stent System for Weight Loss: A Multicentre Real‐World Study

    Cohort study

  15. Obesity (Silver Spring)

    Neighborhood‐Level Variation in the Effectiveness of Intensive Health Behavior and Lifestyle Treatment for Pediatric Obesity

    Cohort study

  16. Diabetes Obes Metab

    Preferences for Obesity Medications Among People With Overweight or Obesity in the United States: A Discrete‐Choice Experiment ( OPTIC )

    Cross-sectional study

  17. Diabetes Obes Metab

    Real‐World Adherence Trajectories of GLP ‐1 Receptor Agonists Among Adults and Paediatric Patients With Obesity

    Cohort study

  18. Int J Obes (Lond)

    Body mass index and regional brain N-acetylaspartate: a systematic review and meta-analysis of ¹H-MRS studies

    Meta-analysis

  19. Int J Obes (Lond)

    Changes in plasma levels of a selected panel of miRNAs do not explain the shift from cholesterol-synthesizer to cholesterol-absorber phenotype in men with abdominal obesity after diet-induced weight loss

    Randomized controlled trial

  20. Diabetes Obes Metab

    Obesity and Midlife Performance: A Cross‐Sectional and Longitudinal Analysis of Women in the Menarche‐To‐ PreMenopause Study

    Cross-sectional study

  21. Diabetes Obes Metab

    Psychiatric Safety of GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists in Adolescents With Obesity

    Cohort study

  22. Pediatr Obes

    Associations Between Paternal Pre‐Conceptional Body Mass Index and Lifestyle Factors and Offspring Weight Development

    Secondary analysis

  23. Int J Obes (Lond)

    Sociodemographic and socioeconomic differences in the use of anti-obesity medications: a register study among 282,307 Finnish adults

    Cohort study

  24. J Clin Endocrinol Metab

    Oxytocin-induced changes in free T3/free T4 ratio and relationship with quality of life in adults with obesity

    Secondary analysis

  25. Obesity (Silver Spring)

    Weight Loss and Physical Activity Reduces Perceived Physical Fatigability Among Older Adults With Obesity

    Randomized controlled trial

  26. Diabetes Res Clin Pract

    Associations of atherogenic index of plasma and its related obesity‑composite indices with cardiometabolic multimorbidity across glycemic states: A prospective cohort study of Chinese middle‑aged and older adults

    Cohort study

  27. Diabetes Obes Metab

    Dual Energy X‐Ray Absorptiometry Reveals Differential Glycemic Implications of Adiposity in Underweight, Normal Weight, and Overweight South African Women With Newly‐Diagnosed Diabetes

    Cross-sectional study

  28. Diabetes Obes Metab

    GLP ‐1 Receptor Agonists Post‐Bariatric Surgery ( GRABS ) Trial: Rationale, Design and Baseline Characteristics

    Randomized controlled trial

  29. Diabetes Obes Metab

    Safety, Pharmacokinetics and Pharmacodynamics of the GLP ‐1/ GIP / GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo‐Controlled Phase 1a/1b Study

    Randomized controlled trial

  30. Obesity (Silver Spring)

    Joint Effects of Long‐Term Obesity and Genetic Susceptibility on Sex‐Specific Brain Aging

    Cohort study

  31. BMJ Open Diabetes Res Care

    Body composition displays expected and unexpected contributions to blood pressure and glycemia in young South African women

    Cross-sectional study

  32. Diabetes Obes Metab

    Postmarketing Safety Signals and Medication‐Use Risks of GLP ‐1‐Based Therapies in Diabetes and Obesity: A Multi‐Source Pharmacovigilance and Regulatory Evidence‐Mapping Study

    Research article

  33. Pediatr Obes

    Hepatic Steatosis and Cardiovascular Risk in Obesity: A 10‐Year Follow‐Up Study From Childhood Into Young Adulthood

    Cohort study

  34. Int J Obes (Lond)

    From measured BMI to documented obesity in hospitalized adults: a decade-long analysis and implications for cardiometabolic care

    Cross-sectional study

  35. Diabetes Obes Metab

    Quality Plus Quantity: Evaluation of a Virtual GLP ‐1 Programme With Physical Activity Support to Promote Healthy Body Composition Change During GLP ‐1 Weight Loss

    Mechanistic study

  36. JAMA Netw Open

    Unhealthy Food Television Advertising and Body Weight in Mexican Children

    Cross-sectional study

  37. Obesity (Silver Spring)

    Biological Pathways of Strength Preservation During Calorie Restriction‐Induced Weight Loss Among Adults Without Obesity

    Secondary analysis

  38. Diabetes Obes Metab

    Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits

    Cross-sectional study

  39. Diabetes Obes Metab

    Development of a Parsimonious Sagittal Abdominal Diameter‐Based Model for Estimating Visceral Fat Area in Central Obesity Assessment

    Cross-sectional study

  40. Obesity (Silver Spring)

    Divergent Obesity Classification Between the Edmonton Obesity Staging System and the Lancet Commission Model

    Cross-sectional study

All 2,541 Briefs in ExploreShowing Briefs 41–80 of 2,541, newest first